Adel T. Aref
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Worldwide Innovative Network Consortium: Building a Common Global Cancer Database.
Journal: JCO global oncology
Published: August 13, 2026
Correction: Proteomic-based stratification of intermediate-risk prostate cancer patients.
Journal: Life science alliance
Published: November 08, 2025
Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction using three independent cohorts.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 27, 2025
Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction Using Three Independent Cohorts.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 27, 2025
Predictive Biomarkers of Antibody-Drug Conjugate Efficacy for Solid Tumors: Current Challenges and the Potential Role of Quantitative Proteomics.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 19, 2025
Mapping the Proteomic Landscape of Pancreatic Cancer: Prognostic Insights and Subtype Stratification.
Journal: Cancer research communications
Published: April 30, 2025
Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients.
Journal: Oncotarget
Published: March 12, 2025
Federated Deep Learning Enables Cancer Subtyping by Proteomics.
Journal: Cancer discovery
Published: October 18, 2024
DeePathNet: A Transformer-Based Deep Learning Model Integrating Multiomic Data with Cancer Pathways.
DeePathNet: A Transformer-Based Deep Learning Model Integrating Multiomic Data with Cancer Pathways.
Journal: Cancer research communications
Published: May 19, 2024
A Proteomic Signature for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence.
Journal: Cancer research communications
Published: October 18, 2023
Proteomic-based stratification of intermediate-risk prostate cancer patients.
Journal: Life science alliance
Published: May 09, 2023
Last Updated: 09/26/2026